The future of HL7 in cancer care looks promising, with advancements in technology and increased emphasis on personalized medicine. As more healthcare providers adopt HL7 standards, the interoperability and quality of cancer care are expected to improve. Additionally, emerging technologies such as Artificial Intelligence and Machine Learning are likely to further enhance the capabilities of HL7, leading to more efficient and effective cancer treatments.
